APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Weight Loss Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global GLP-1 Weight Loss Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173995430326 December 2025199 pages

Choose your research edition.

Industry ResearchGLP-1 Weight Loss Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Weight Loss Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal GLP-1 Weight Loss Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Weight Loss Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Weight Loss Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global GLP-1 Weight Loss Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for GLP-1 Weight Loss Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GLP-1 Weight Loss Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP-1 Weight Loss Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for GLP-1 Weight Loss Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GLP-1 Weight Loss Injection include Novo Nordisk, Imeik, Borui Pharmaceuticals, Gan & Lee Pharmaceuticals, Hansoh Pharmaceuticals, Hengrui Medicine, Huadong Medicine, Eli Lilly and Shanghai Benemae Biopharmaceuticals Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GLP-1 Weight Loss Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GLP-1 Weight Loss Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GLP-1 Weight Loss Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GLP-1 Weight Loss Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

GLP-1 Weight Loss Injection Segment by Company

Novo Nordisk

Imeik

Borui Pharmaceuticals

Gan & Lee Pharmaceuticals

Hansoh Pharmaceuticals

Hengrui Medicine

Huadong Medicine

Eli Lilly

Shanghai Benemae Biopharmaceuticals Co., Ltd.

CSPC Pharmaceutical Group

Sihuan Pharmaceuticals

Wanbang Biopharma

Innovent Biologics

GLP-1 Weight Loss Injection Segment by Type

Tirzepatide

Semaglutide

Liraglutide

Benaglutide

Others

GLP-1 Weight Loss Injection Segment by Application

Hospital

Clinic

Others

GLP-1 Weight Loss Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Weight Loss Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Weight Loss Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Weight Loss Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GLP-1 Weight Loss Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GLP-1 Weight Loss Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of GLP-1 Weight Loss Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of GLP-1 Weight Loss Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. GLP-1 Weight Loss Injection Industry Trends Table 2. GLP-1 Weight Loss Injection Industry Drivers Table 3. GLP-1 Weight Loss Injection Industry Opportunities and Challenges Table 4. GLP-1 Weight Loss Injection Industry Restraints Table 5. Global GLP-1 Weight Loss Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global GLP-1 Weight Loss Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global GLP-1 Weight Loss Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global GLP-1 Weight Loss Injection Sales Market Share by Manufacturers Table 9. Global GLP-1 Weight Loss Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global GLP-1 Weight Loss Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global GLP-1 Weight Loss Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global GLP-1 Weight Loss Injection Manufacturers, Product Type & Application Table 13. Global GLP-1 Weight Loss Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global GLP-1 Weight Loss Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tirzepatide Table 17. Major Manufacturers of Semaglutide Table 18. Major Manufacturers of Liraglutide Table 19. Major Manufacturers of Benaglutide Table 20. Major Manufacturers of Others Table 21. Global GLP-1 Weight Loss Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global GLP-1 Weight Loss Injection Sales by Type (2021-2026) & (K Units) Table 23. Global GLP-1 Weight Loss Injection Sales by Type (2027-2032) & (K Units) Table 24. Global GLP-1 Weight Loss Injection Sales Market Share by Type (2021-2026) Table 25. Global GLP-1 Weight Loss Injection Sales Market Share by Type (2027-2032) Table 26. Global GLP-1 Weight Loss Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global GLP-1 Weight Loss Injection Revenue by Type (2021-2026) & (K Units) Table 28. Global GLP-1 Weight Loss Injection Revenue by Type (2027-2032) & (K Units) Table 29. Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2021-2026) Table 30. Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Others Table 34. Global GLP-1 Weight Loss Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global GLP-1 Weight Loss Injection Sales by Application (2021-2026) & (K Units) Table 36. Global GLP-1 Weight Loss Injection Sales by Application (2027-2032) & (K Units) Table 37. Global GLP-1 Weight Loss Injection Sales Market Share by Application (2021-2026) Table 38. Global GLP-1 Weight Loss Injection Sales Market Share by Application (2027-2032) Table 39. Global GLP-1 Weight Loss Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global GLP-1 Weight Loss Injection Revenue by Application (2021-2026) & (K Units) Table 41. Global GLP-1 Weight Loss Injection Revenue by Application (2027-2032) & (K Units) Table 42. Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2021-2026) Table 43. Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2027-2032) Table 44. Global GLP-1 Weight Loss Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global GLP-1 Weight Loss Injection Sales by Region (2021-2026) & (K Units) Table 46. Global GLP-1 Weight Loss Injection Sales Market Share by Region (2021-2026) Table 47. Global GLP-1 Weight Loss Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global GLP-1 Weight Loss Injection Sales Forecasted Market Share by Region (2027-2032) Table 49. North America GLP-1 Weight Loss Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America GLP-1 Weight Loss Injection Sales by Country (2021-2026) & (K Units) Table 51. North America GLP-1 Weight Loss Injection Sales by Country (2027-2032) & (K Units) Table 52. Europe GLP-1 Weight Loss Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe GLP-1 Weight Loss Injection Sales by Country (2021-2026) & (K Units) Table 54. Europe GLP-1 Weight Loss Injection Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific GLP-1 Weight Loss Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific GLP-1 Weight Loss Injection Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific GLP-1 Weight Loss Injection Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa GLP-1 Weight Loss Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa GLP-1 Weight Loss Injection Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa GLP-1 Weight Loss Injection Sales by Country (2027-2032) & (K Units) Table 61. Global GLP-1 Weight Loss Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global GLP-1 Weight Loss Injection Revenue by Region (2021-2026) & (US$ Million) Table 63. Global GLP-1 Weight Loss Injection Revenue by Region (2027-2032) & (US$ Million) Table 64. Global GLP-1 Weight Loss Injection Revenue Market Share by Region (2021-2026) Table 65. Global GLP-1 Weight Loss Injection Revenue Market Share by Region (2027-2032) Table 66. Novo Nordisk Company Information Table 67. Novo Nordisk Business Overview Table 68. Novo Nordisk GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Novo Nordisk GLP-1 Weight Loss Injection Product Portfolio Table 70. Novo Nordisk Recent Development Table 71. Imeik Company Information Table 72. Imeik Business Overview Table 73. Imeik GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Imeik GLP-1 Weight Loss Injection Product Portfolio Table 75. Imeik Recent Development Table 76. Borui Pharmaceuticals Company Information Table 77. Borui Pharmaceuticals Business Overview Table 78. Borui Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Borui Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 80. Borui Pharmaceuticals Recent Development Table 81. Gan & Lee Pharmaceuticals Company Information Table 82. Gan & Lee Pharmaceuticals Business Overview Table 83. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 85. Gan & Lee Pharmaceuticals Recent Development Table 86. Hansoh Pharmaceuticals Company Information Table 87. Hansoh Pharmaceuticals Business Overview Table 88. Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 90. Hansoh Pharmaceuticals Recent Development Table 91. Hengrui Medicine Company Information Table 92. Hengrui Medicine Business Overview Table 93. Hengrui Medicine GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Hengrui Medicine GLP-1 Weight Loss Injection Product Portfolio Table 95. Hengrui Medicine Recent Development Table 96. Huadong Medicine Company Information Table 97. Huadong Medicine Business Overview Table 98. Huadong Medicine GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Huadong Medicine GLP-1 Weight Loss Injection Product Portfolio Table 100. Huadong Medicine Recent Development Table 101. Eli Lilly Company Information Table 102. Eli Lilly Business Overview Table 103. Eli Lilly GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Eli Lilly GLP-1 Weight Loss Injection Product Portfolio Table 105. Eli Lilly Recent Development Table 106. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information Table 107. Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview Table 108. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Product Portfolio Table 110. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Development Table 111. CSPC Pharmaceutical Group Company Information Table 112. CSPC Pharmaceutical Group Business Overview Table 113. CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Product Portfolio Table 115. CSPC Pharmaceutical Group Recent Development Table 116. Sihuan Pharmaceuticals Company Information Table 117. Sihuan Pharmaceuticals Business Overview Table 118. Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio Table 120. Sihuan Pharmaceuticals Recent Development Table 121. Wanbang Biopharma Company Information Table 122. Wanbang Biopharma Business Overview Table 123. Wanbang Biopharma GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Wanbang Biopharma GLP-1 Weight Loss Injection Product Portfolio Table 125. Wanbang Biopharma Recent Development Table 126. Innovent Biologics Company Information Table 127. Innovent Biologics Business Overview Table 128. Innovent Biologics GLP-1 Weight Loss Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Innovent Biologics GLP-1 Weight Loss Injection Product Portfolio Table 130. Innovent Biologics Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. GLP-1 Weight Loss Injection Distributors List Table 134. GLP-1 Weight Loss Injection Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. GLP-1 Weight Loss Injection Product Image Figure 2. Global GLP-1 Weight Loss Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Weight Loss Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global GLP-1 Weight Loss Injection Sales (2021-2032) & (K Units) Figure 5. Global GLP-1 Weight Loss Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 GLP-1 Weight Loss Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tirzepatide Image Figure 9. Semaglutide Image Figure 10. Liraglutide Image Figure 11. Benaglutide Image Figure 12. Others Image Figure 13. Global GLP-1 Weight Loss Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global GLP-1 Weight Loss Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global GLP-1 Weight Loss Injection Sales Market Share by Type (2021-2032) Figure 16. Global GLP-1 Weight Loss Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global GLP-1 Weight Loss Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global GLP-1 Weight Loss Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global GLP-1 Weight Loss Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global GLP-1 Weight Loss Injection Sales Market Share by Application (2021-2032) Figure 25. Global GLP-1 Weight Loss Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global GLP-1 Weight Loss Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2021-2032) Figure 28. North America GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America GLP-1 Weight Loss Injection Sales Market Share by Country (2021-2032) Figure 30. U.S. GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe GLP-1 Weight Loss Injection Sales Market Share by Country (2021-2032) Figure 35. Germany GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific GLP-1 Weight Loss Injection Sales Market Share by Country (2021-2032) Figure 42. China GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa GLP-1 Weight Loss Injection Sales Market Share by Country (2021-2032) Figure 50. Brazil GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile GLP-1 Weight Loss Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global GLP-1 Weight Loss Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global GLP-1 Weight Loss Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Figure 61. North America GLP-1 Weight Loss Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Figure 63. Europe GLP-1 Weight Loss Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific GLP-1 Weight Loss Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa GLP-1 Weight Loss Injection Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa GLP-1 Weight Loss Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. GLP-1 Weight Loss Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. GLP-1 Weight Loss Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tirzepatide
  • Semaglutide
  • Liraglutide
  • Benaglutide
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novo Nordisk
  • Imeik
  • Borui Pharmaceuticals
  • Gan & Lee Pharmaceuticals
  • Hansoh Pharmaceuticals
  • Hengrui Medicine
  • Huadong Medicine
  • Eli Lilly
  • Shanghai Benemae Biopharmaceuticals Co., Ltd.
  • CSPC Pharmaceutical Group
  • Sihuan Pharmaceuticals
  • Wanbang Biopharma
  • Innovent Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global GLP-1 Weight Loss Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global GLP-1 Weight Loss Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global GLP-1 Weight Loss Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global GLP-1 Weight Loss Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global GLP-1 Weight Loss Injection Market Dynamics
  1. 2.1 GLP-1 Weight Loss Injection Industry Trends
  2. 2.2 GLP-1 Weight Loss Injection Industry Drivers
  3. 2.3 GLP-1 Weight Loss Injection Industry Opportunities and Challenges
  4. 2.4 GLP-1 Weight Loss Injection Industry Restraints
3 GLP-1 Weight Loss Injection Market by Manufacturers
  1. 3.1 Global GLP-1 Weight Loss Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global GLP-1 Weight Loss Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global GLP-1 Weight Loss Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global GLP-1 Weight Loss Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GLP-1 Weight Loss Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global GLP-1 Weight Loss Injection Manufacturers, Product Type & Application
  7. 3.7 Global GLP-1 Weight Loss Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GLP-1 Weight Loss Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GLP-1 Weight Loss Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GLP-1 Weight Loss Injection Tier 1, Tier 2, and Tier 3
4 GLP-1 Weight Loss Injection Market by Type
  1. 4.1 GLP-1 Weight Loss Injection Type Introduction
  2. 4.1.1 Tirzepatide
  3. 4.1.2 Semaglutide
  4. 4.1.3 Liraglutide
  5. 4.1.4 Benaglutide
  6. 4.1.5 Others
  7. 4.2 Global GLP-1 Weight Loss Injection Sales by Type
  8. 4.2.1 Global GLP-1 Weight Loss Injection Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global GLP-1 Weight Loss Injection Sales by Type (2021-2032)
  10. 4.2.3 Global GLP-1 Weight Loss Injection Sales Market Share by Type (2021-2032)
  11. 4.3 Global GLP-1 Weight Loss Injection Revenue by Type
  12. 4.3.1 Global GLP-1 Weight Loss Injection Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global GLP-1 Weight Loss Injection Revenue by Type (2021-2032)
  14. 4.3.3 Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2021-2032)
5 GLP-1 Weight Loss Injection Market by Application
  1. 5.1 GLP-1 Weight Loss Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global GLP-1 Weight Loss Injection Sales by Application
  6. 5.2.1 Global GLP-1 Weight Loss Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GLP-1 Weight Loss Injection Sales by Application (2021-2032)
  8. 5.2.3 Global GLP-1 Weight Loss Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global GLP-1 Weight Loss Injection Revenue by Application
  10. 5.3.1 Global GLP-1 Weight Loss Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global GLP-1 Weight Loss Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2021-2032)
6 Global GLP-1 Weight Loss Injection Sales by Region
  1. 6.1 Global GLP-1 Weight Loss Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GLP-1 Weight Loss Injection Sales by Region (2021-2032)
  3. 6.2.1 Global GLP-1 Weight Loss Injection Sales by Region (2021-2026)
  4. 6.2.2 Global GLP-1 Weight Loss Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America GLP-1 Weight Loss Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America GLP-1 Weight Loss Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe GLP-1 Weight Loss Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe GLP-1 Weight Loss Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific GLP-1 Weight Loss Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific GLP-1 Weight Loss Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa GLP-1 Weight Loss Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa GLP-1 Weight Loss Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global GLP-1 Weight Loss Injection Revenue by Region
  1. 7.1 Global GLP-1 Weight Loss Injection Revenue by Region
  2. 7.1.1 Global GLP-1 Weight Loss Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global GLP-1 Weight Loss Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global GLP-1 Weight Loss Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global GLP-1 Weight Loss Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America GLP-1 Weight Loss Injection Revenue (2021-2032)
  8. 7.2.2 North America GLP-1 Weight Loss Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe GLP-1 Weight Loss Injection Revenue (2021-2032)
  11. 7.3.2 Europe GLP-1 Weight Loss Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific GLP-1 Weight Loss Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific GLP-1 Weight Loss Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa GLP-1 Weight Loss Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa GLP-1 Weight Loss Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk GLP-1 Weight Loss Injection Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 Imeik
  8. 8.2.1 Imeik Company Information
  9. 8.2.2 Imeik Business Overview
  10. 8.2.3 Imeik GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Imeik GLP-1 Weight Loss Injection Product Portfolio
  12. 8.2.5 Imeik Recent Developments
  13. 8.3 Borui Pharmaceuticals
  14. 8.3.1 Borui Pharmaceuticals Company Information
  15. 8.3.2 Borui Pharmaceuticals Business Overview
  16. 8.3.3 Borui Pharmaceuticals GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Borui Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  18. 8.3.5 Borui Pharmaceuticals Recent Developments
  19. 8.4 Gan & Lee Pharmaceuticals
  20. 8.4.1 Gan & Lee Pharmaceuticals Company Information
  21. 8.4.2 Gan & Lee Pharmaceuticals Business Overview
  22. 8.4.3 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  24. 8.4.5 Gan & Lee Pharmaceuticals Recent Developments
  25. 8.5 Hansoh Pharmaceuticals
  26. 8.5.1 Hansoh Pharmaceuticals Company Information
  27. 8.5.2 Hansoh Pharmaceuticals Business Overview
  28. 8.5.3 Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  30. 8.5.5 Hansoh Pharmaceuticals Recent Developments
  31. 8.6 Hengrui Medicine
  32. 8.6.1 Hengrui Medicine Company Information
  33. 8.6.2 Hengrui Medicine Business Overview
  34. 8.6.3 Hengrui Medicine GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hengrui Medicine GLP-1 Weight Loss Injection Product Portfolio
  36. 8.6.5 Hengrui Medicine Recent Developments
  37. 8.7 Huadong Medicine
  38. 8.7.1 Huadong Medicine Company Information
  39. 8.7.2 Huadong Medicine Business Overview
  40. 8.7.3 Huadong Medicine GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Huadong Medicine GLP-1 Weight Loss Injection Product Portfolio
  42. 8.7.5 Huadong Medicine Recent Developments
  43. 8.8 Eli Lilly
  44. 8.8.1 Eli Lilly Company Information
  45. 8.8.2 Eli Lilly Business Overview
  46. 8.8.3 Eli Lilly GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly GLP-1 Weight Loss Injection Product Portfolio
  48. 8.8.5 Eli Lilly Recent Developments
  49. 8.9 Shanghai Benemae Biopharmaceuticals Co., Ltd.
  50. 8.9.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
  51. 8.9.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview
  52. 8.9.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Product Portfolio
  54. 8.9.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments
  55. 8.10 CSPC Pharmaceutical Group
  56. 8.10.1 CSPC Pharmaceutical Group Company Information
  57. 8.10.2 CSPC Pharmaceutical Group Business Overview
  58. 8.10.3 CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Product Portfolio
  60. 8.10.5 CSPC Pharmaceutical Group Recent Developments
  61. 8.11 Sihuan Pharmaceuticals
  62. 8.11.1 Sihuan Pharmaceuticals Company Information
  63. 8.11.2 Sihuan Pharmaceuticals Business Overview
  64. 8.11.3 Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
  66. 8.11.5 Sihuan Pharmaceuticals Recent Developments
  67. 8.12 Wanbang Biopharma
  68. 8.12.1 Wanbang Biopharma Company Information
  69. 8.12.2 Wanbang Biopharma Business Overview
  70. 8.12.3 Wanbang Biopharma GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Wanbang Biopharma GLP-1 Weight Loss Injection Product Portfolio
  72. 8.12.5 Wanbang Biopharma Recent Developments
  73. 8.13 Innovent Biologics
  74. 8.13.1 Innovent Biologics Company Information
  75. 8.13.2 Innovent Biologics Business Overview
  76. 8.13.3 Innovent Biologics GLP-1 Weight Loss Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Innovent Biologics GLP-1 Weight Loss Injection Product Portfolio
  78. 8.13.5 Innovent Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GLP-1 Weight Loss Injection Value Chain Analysis
  2. 9.1.1 GLP-1 Weight Loss Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GLP-1 Weight Loss Injection Production Mode & Process
  6. 9.2 GLP-1 Weight Loss Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GLP-1 Weight Loss Injection Distributors
  9. 9.2.3 GLP-1 Weight Loss Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst